WallStreetZenWallStreetZen

NASDAQ: CAPR
Capricor Therapeutics Inc Stock Ownership - Who owns Capricor Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Capricor Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Anthony BergmannCHIEF FINANCIAL OFFICER2026-06-2524,100$3.18
$76.64kBuy
Karen KrasneyEVP GENERAL COUNSEL2026-06-2524,100$3.18
$76.64kBuy
Karen KrasneyEVP GENERAL COUNSEL2026-06-2524,100$30.38
$732.16kSell
Anthony BergmannCHIEF FINANCIAL OFFICER2026-06-2524,100$30.38
$732.16kSell
Karen KrasneyEVP GENERAL COUNSEL2026-06-24400$30.00
$12.00kSell
Anthony BergmannCHIEF FINANCIAL OFFICER2026-06-24400$3.18
$1.27kBuy
Anthony BergmannCHIEF FINANCIAL OFFICER2026-06-24400$30.00
$12.00kSell
Karen KrasneyEVP GENERAL COUNSEL2026-06-24400$3.18
$1.27kBuy
Karen KrasneyEVP GENERAL COUNSEL2026-06-22500$30.00
$15.00kSell
Anthony BergmannCHIEF FINANCIAL OFFICER2026-06-22500$30.00
$15.00kSell

1 of 4

CAPR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CAPR insiders and whales buy or sell their stock.

CAPR Shareholders

What type of owners hold Capricor Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nippon Shinyaku Co Ltd12.20%7,090,351$66.79MInsider
Fountainhead Capital Partners Ltd9.55%5,551,000$52.29MInsider
Sinai Medical Center Cedars6.97%4,049,959$38.15MInsider
Eduardo Marban5.69%3,307,863$31.16MInsider
John Edward A. St5.33%3,101,574$29.22MInsider
Louis J. Grasmick5.05%2,937,729$27.67MInsider
Peter M. Kash5.02%2,920,446$27.51MInsider
Wexford Capital LP4.48%2,606,778$24.56MInsider
Peter Morgan Kash3.70%2,153,913$20.29MInsider
David M. Tanen3.33%1,934,528$18.22MInsider

1 of 3

CAPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAPR0.07%67.01%Net BuyingNet Buying
TECX0.04%99.96%Net BuyingNet Selling
OVID0.08%9.54%Net Buying
RGNX0.06%19.73%Net SellingNet Buying
DNA0.01%99.99%Net SellingNet Selling
View Top Biotech Stocks

Capricor Therapeutics Stock Ownership FAQ

Who owns Capricor Therapeutics?

Capricor Therapeutics (NASDAQ: CAPR) is owned by 0.07% institutional shareholders, 67.01% Capricor Therapeutics insiders, and 32.93% retail investors. Nippon Shinyaku Co Ltd is the largest individual Capricor Therapeutics shareholder, owning 7.09M shares representing 12.20% of the company. Nippon Shinyaku Co Ltd's Capricor Therapeutics shares are currently valued at $64.24M.

If you're new to stock investing, here's how to buy Capricor Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.